CTTI Recommends New Vaccine Approaches

August 1, 2016

The Clinical Trials Transformation Initiative (CTTI) have released recommendations for hospital acquired and ventilator-associated bacterial pneumonia (HABP/VABP) as part of its antibacterial drug development program.

The Clinical Trials Transformation Initiative (CTTI) have released recommendations for hospital acquired and ventilator-associated bacterial pneumonia (HABP/VABP) as part of its antibacterial drug development program. The recommendations outline clinical trial approaches such as early enrollment strategies and streamlining the collection of safety data.

Read the full release here

Related Content:

News